Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03976362
Brief Title: A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)

First Submitted : June 3, 2019
First Submitted that Met QC Criteria : June 3, 2019
First Posted : June 6, 2019

Last Update Submitted that Met QC Criteria : February 27, 2022
Last Update Posted : March 14, 2022